KEYTRUDA now approved for 23 uses in 13 different types of cancer in Japan RAHWAY, N.J. — Merck (NYSE: MRK), known as MSD outside of the United States and Canada,… Read More
OTTAWA, ON – Following their Annual General Meeting, BioTalent Canada has broadened its leadership team with the announcement of 16 new and returning Board Members. Under the guidance of returning Chair, Reg… Read More
VICTORIA, BC — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced the grant of… Read More
BURNABY, BC – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform designed to restore innate immune function, is pleased to announce… Read More
NEW YORK & MAINZ, GERMANY — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA)… Read More
